FDA NDC Directory · JSON-LD · Markdown

CIMERLI

NDC 61314-625 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameranibizumab-eqrn
Labeler / ManufacturerSandoz Inc
Marketing categoryBiologic License Application · App BLA761165
Dosage form / routeINJECTION, SOLUTION · INTRAVITREAL
Active ingredientsRANIBIZUMAB (.5 mg/.05mL)
Marketing started20241212
Package count1

External sources

Source: openFDA. Public-domain (CC0).